Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing (Q42215713)

18 October 2017

title

Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing (English)

1 reference

18 October 2017

2

1 reference

18 October 2017

10

1 reference

18 October 2017

14

1 reference

18 October 2017

Bonaventura Clotet Sala

17

object named as

Bonaventura Clotet

1 reference

18 October 2017

Federico Pulido

11

0 references

author name string

Christian Pou

1

1 reference

18 October 2017

Susana Pérez-Álvarez

3

1 reference

18 October 2017

Federico García

4

1 reference

18 October 2017

Rafael Delgado

5

1 reference

18 October 2017

David Dalmau

6

1 reference

18 October 2017

Miguel Álvarez-Tejado

7

1 reference

18 October 2017

Dimitri Gonzalez

8

1 reference

18 October 2017

Chalom Sayada

9

1 reference

18 October 2017

Laura Ibáñez

12

1 reference

18 October 2017

Cristina Rodríguez

13

1 reference

18 October 2017

José R Santos

15

1 reference

18 October 2017

Lidia Ruiz

16

1 reference

18 October 2017

Roger Paredes

18

1 reference

18 October 2017

language of work or name

English

0 references

publication date

29 May 2014

1 reference

Clinical Infectious Diseases

18 October 2017

published in

1 reference

18 October 2017

volume

59

1 reference

18 October 2017

issue

4

1 reference

18 October 2017

page(s)

578-588

1 reference

Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Prevention of HIV-1 infection with early antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Clinical implications of HIV-1 minority variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Response to antiretroviral therapy after a single, peripartum dose of nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Next-generation sequencing to assess HIV tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU287

21 January 2018

Identifiers

DOI

10.1093/CID/CIU287

1 reference

18 October 2017

1 reference